Stemedica

0 Followers

As one of the world’s foremost developers of allogeneic adult stem cells for research and clinical trials, Stemedica Cell Technologies, Inc., of San Diego, California, partners with major medical and academic centers to support preclinical and clinical studies. The privately held biopharmaceutical company produces high-quality stem cells derived from adult bone marrow, brain tissue, and retinal epithelium. Stemedica processes all three types of stem cells in a low-oxygen environment in order to encourage their ischemic-tolerant properties.

stemedica stemedica cell technologies patent stem cell transplants heart trials stem cell ischemic strokes health medicine heart attack patients research mesenchymal stem cell trials stem cell testing inc technology stem cell trials subsidiary stem cell health alliance new procedure stem cell treatment stem cell research

Activity
About

Stemedica

Presentations

Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies’ Subsidiary Starts Stem Cell Trials

The Causes of Ischemic Strokes

Two Heart Stem Cell Trials

Stem Cell Transplants